pentamidine has been researched along with Lymphocytopenia in 2 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a retrospective and descriptive study of four immunocompromised patients (three with HIV-1 and one with idiopathic CD4+-lymphopenia) with relapsing visceral leishmaniasis seen at the Hospital for Tropical Diseases, London, in whom pentamidine was used as secondary prophylaxis to prevent relapse." | 3.75 | Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. ( Lockwood, DN; Patel, TA, 2009) |
| "International guidelines for Pneumocystis jirovecii pneumonia (PJP) prevention recommend prophylaxis for ≥6 months following allogeneic hematopoietic cell transplantation, and longer in patients with graft-versus-host disease (GVHD) or on immunosuppressive therapy (IST)." | 1.56 | High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era. ( Chaudhry, A; Dabas, R; Daly, A; Dharmani-Khan, P; Dowhan, M; Duggan, P; Evernden, C; Gregson, D; Jamani, K; Jimenez-Zepeda, V; Johnson, A; Jupp, J; Kalra, A; Khan, F; Storek, J; Tay, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evernden, C | 1 |
| Dowhan, M | 1 |
| Dabas, R | 1 |
| Chaudhry, A | 1 |
| Kalra, A | 1 |
| Dharmani-Khan, P | 1 |
| Gregson, D | 1 |
| Johnson, A | 1 |
| Jupp, J | 1 |
| Jimenez-Zepeda, V | 1 |
| Jamani, K | 1 |
| Duggan, P | 1 |
| Tay, J | 1 |
| Khan, F | 1 |
| Daly, A | 1 |
| Storek, J | 1 |
| Patel, TA | 1 |
| Lockwood, DN | 1 |
2 other studies available for pentamidine and Lymphocytopenia
| Article | Year |
|---|---|
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antilymphocyte Serum; Atovaquone; CD4 Lymphocyte Cou | 2020 |
Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; HIV- | 2009 |